Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium

Autor: Lupiañez, C. B., Canet, L. M., Carvalho, Agostinho Albérico Rodrigues de, Alcazar-Fuolie, L., Springer, J., Lacknerg, M., Segura-Catena, J., Comino, A., Olmedo, C., Ríosa, R., Fernández-Montoya, A., Cuenca-Estrella, M., Solano, C., López-Nevotk, M. Á., Cunha, Cristina Amorim, Coelho, Ana do Carmo Oliveira, Villaescusal, T., Fianchin, L., Aguado, J. M., Paganon, L., López-Fernández, E., Potenza, L., Luppip, M., Lass-Flörlg, C., Loefflerf, J., Einselef, H., Vazquez, L., PCRAGA Study Group, Jurado, M., Sainza, J.

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

Recent studies suggest that immune-modulating single nucleotide polymorphisms (SNPs) influence the risk of developing cancer-related infections. Here, we evaluated whether 36 SNPs within 14 immune-related genes are associated with the risk of Invasiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5ca2026cd66049ceb11e50cd9044ae1
http://hdl.handle.net/10807/72769

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Polymorphisms within the ARNT2and CX3CR1Genes Are Associated with the Risk of Developing Invasive Aspergillosis

Autor: Lupiañez, C. B., Martínez-Bueno, M., Sánchez-Maldonado, J. M., Badiola, J., Cunha, C., Springer, J., Lackner, M., Segura-Catena, J., Canet, L. M., Alcazar-Fuoli, L., López-Nevot, M. A., Fianchi, L., Aguado, J. M., Pagano, L., López-Fernández, E., Alarcón-Riquelme, M., Potenza, L., Gonçalves, S. M., Luppi, M., Moratalla, L., Solano, C., Sampedro, A., González-Sierra, P., Cuenca-Estrella, M., Lagrou, K., Maertens, J. A., Lass-Flörl, C., Einsele, H., Vazquez, L., Loeffler, J., Ríos-Tamayo, R., Carvalho, A., Jurado, M., Sainz, J.

Publikováno v: Infection and Immunity; March 2020, Vol. 88 Issue: 4

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis.

Autor: Lupiañez CB; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Martínez-Bueno M; Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Sánchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Badiola J; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Cunha C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Springer J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Segura-Catena J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Canet LM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Alcazar-Fuoli L; Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain., López-Nevot MA; Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain., Fianchi L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., Aguado JM; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre,' Instituto de Investigación Hospital '12 de Octubre' (i+12), Madrid, Spain., Pagano L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., López-Fernández E; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Alarcón-Riquelme M; Genomic Medicine Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Gonçalves SM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Moratalla L; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Solano C; Hematology Department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Spain., Sampedro A; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.; Department of Microbiology, Virgen de las Nieves University Hospital, Granada, Spain., González-Sierra P; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Cuenca-Estrella M; Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain., Lagrou K; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.; Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium.; National Reference Center for Medical Mycology, University Hospitals Leuven, Leuven, Belgium., Maertens JA; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Vazquez L; Hematology Department, University Hospital of Salamanca, Salamanca, Spain., Loeffler J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Ríos-Tamayo R; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Carvalho A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Jurado M; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain juan.sainz@genyo.es.; Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.

Publikováno v: Infection and immunity [Infect Immun] 2020 Mar 23; Vol. 88 (4). Date of Electronic Publication: 2020 Mar 23 (Print Publication: 2020).